Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy—Pilot Study
Turon-Skrzypinska, A.; Dutkiewicz, G.; Marchelek-Mysliwiec, M.; Dziedziejko, V.; Ciechanowski, K.; Ryl, A.; Rotter, I. Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy—Pilot Study. Medicina 2019, 55, 784. https://doi.org/10.3390/medicina55120784
Turon-Skrzypinska A, Dutkiewicz G, Marchelek-Mysliwiec M, Dziedziejko V, Ciechanowski K, Ryl A, Rotter I. Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy—Pilot Study. Medicina. 2019; 55(12):784. https://doi.org/10.3390/medicina55120784
Chicago/Turabian StyleTuron-Skrzypinska, Agnieszka; Dutkiewicz, Grazyna; Marchelek-Mysliwiec, Malgorzata; Dziedziejko, Violetta; Ciechanowski, Kazimierz; Ryl, Aleksandra; Rotter, Iwona. 2019. "Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy—Pilot Study" Medicina 55, no. 12: 784. https://doi.org/10.3390/medicina55120784